Redx Pharma (LSE:REDX) Net Margin % : -655.21% (As of Sep. 2023)

Redx Pharma Net Margin % Chart

Redx Pharma Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
Net Margin %		Get a 7-Day Free Trial					-137.91	-162.06	-215.01	-96.33	-789.05

Redx Pharma Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Margin %	Get a 7-Day Free Trial															-111.68	-116.88	-79.73	-898.57	-655.21

Competitive Comparison of Redx Pharma's Net Margin %

For the Biotechnology subindustry, Redx Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redx Pharma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Redx Pharma's Net Margin % falls into.

Redx Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Redx Pharma's Net Margin for the fiscal year that ended in Sep. 2023 is calculated as

Redx Pharma's Net Margin for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redx Pharma  (LSE:REDX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Redx Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Redx Pharma (LSE:REDX) Business Description